Terumo (TRUMY) Stock Price, News & Analysis

Company Overview

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other health care settings. Founded in 1921, the company has grown from producing clinical thermometers into a global provider of medical devices and related solutions.

Terumo’s businesses include cardiovascular and vascular intervention products, such as catheters, guidewires and other devices used in the treatment of heart and vascular conditions. The company also supplies blood management products, including blood bags and automated systems, as well as hospital products such as syringes, infusion systems and injection-related devices. In addition, Terumo develops technologies for therapeutic areas including neurovascular care, aortic treatment and cell and gene therapies.

Terumo serves health care providers and patients in Japan and international markets across the Americas, Europe, Asia and other regions. Its products are marketed through a combination of direct operations, subsidiaries and distribution networks, supporting medical professionals in areas including cardiovascular care, blood management and general hospital practice.

Key Stats

• Today's Range: $14.13 to $14.54
• 50-Day Range: $13.05 to $16.67
• 52-Week Range: $12.08 to $18.04
• Volume: 77,823 shs
• Average Volume: 258,593 shs
• Market Capitalization: $21.14 billion
• P/E Ratio: 20.18
• Dividend Yield: 0.77%
• Price Target: N/A
• Consensus Rating: Buy

Terumo Stock Analysis - MarketRank™

Terumo scored higher than 40% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.7 / 5
• Analyst Rating: Buy

Consensus Rating

Terumo has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Terumo has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 7.14%

Earnings Growth

Earnings for Terumo are expected to grow by 7.14% in the coming year, from $0.70 to $0.75 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Terumo is 20.24, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.03.

Price to Earnings Ratio vs. Sector

The P/E ratio of Terumo is 20.24, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.73.

Price to Book Value per Share Ratio

Terumo has a P/B Ratio of 2.03. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of Terumo has been sold short.

Short Interest Ratio / Days to Cover

Terumo has a short interest ratio ("days to cover") of 0.86, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Terumo has recently increased by 96.32%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Terumo has a dividend yield of 0.74%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Terumo does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Terumo is 15.49%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Terumo will have a dividend payout ratio of 14.67% next year. This indicates that Terumo will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Terumo this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Terumo insiders have not sold or bought any company stock.

Percentage Held by Institutions

Terumo has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/07/2026
• Today: 9/10/2026
• Next Earnings (Estimated): 11/11/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:TRUMY
• Previous Symbol: NASDAQ:TRUMY
• CIK: 1446672
• Web: www.terumo.co.jp
• Phone: (133) 374-8111
• Fax: 813-3374-8399
• Employees: 30,000
• Year Founded: 1964

Profitability

• EPS (Trailing Twelve Months): $0.71
• Trailing P/E Ratio: 20.18
• Forward P/E Ratio: 20.47
• P/E Growth: N/A
• Net Income: $897.03 million
• Net Margins: 13.83%
• Pretax Margin: 15.75%
• Return on Equity: 10.44%
• Return on Assets: 7.34%

Debt

• Debt-to-Equity Ratio: 0.13
• Current Ratio: 2.19
• Quick Ratio: 0.97

Sales & Book Value

• Annual Sales: $7.52 billion
• Price / Sales: 2.81
• Cash Flow: $0.99 per share
• Price / Cash Flow: 14.42
• Book Value: $7.09 per share
• Price / Book: 2.02

Miscellaneous

• Outstanding Shares: 1,475,070,000
• Free Float: N/A
• Market Cap: $21.14 billion
• Optionable: Not Optionable
• Beta: 0.68